BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dadzie TG, Green AC. The role of the bone microenvironment in regulating myeloma residual disease and treatment. Front Oncol 2022;12:999939. [DOI: 10.3389/fonc.2022.999939] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Kikuchi H, Amofa E, Mcenery M, Schey SA, Ramasamy K, Farzaneh F, Calle Y. Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics. Cancers (Basel) 2023;15. [PMID: 36672411 DOI: 10.3390/cancers15020462] [Reference Citation Analysis]
2 Suzuki R, Ogiya D, Ogawa Y, Kawada H, Ando K. Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma. Curr Oncol 2022;29:8529-39. [PMID: 36354732 DOI: 10.3390/curroncol29110672] [Reference Citation Analysis]